Streetbeat News

CURLF

Curaleaf Holdings Inc

Employees

5,138

Industry

Medicinal and Botanical Manufacturing

Open

2.30

Mkt cap

1.6B

Volume

197K

High

2.30

P/E Ratio

-7.03

52-wk high

6.40

Low

2.08

Div yield

N/A

52-wk low

2.07

Marijuana stocks experienced significant movements with Affinor Growers, Rhinomed, and others posting major gains, while 1933 Industries, Indiva, and others saw declines. Notably, OrganiGram Holdings, Tilray Brands, Aurora Cannabis, Cronos Group, SNDL, Psychemedics, Village Farms Intl, GrowGeneration, and Genetic Technologies were among the NASDAQ-listed companies with notable changes.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 9:30 pm

Curaleaf Holdings Inc (OTCQX:CURLF) (TSX:CURA) has expanded its presence in Poland by acquiring Can4Med, a pharmaceutical wholesaler specializing in cannabinoid medications. This move is aimed at enhancing patient access to medical cannabis products across Europe. The acquisition is part of Curaleaf's strategy to capitalize on the rapidly expanding medical cannabis market in Poland, which has seen significant growth in 2023 with over 3,000kg of medical cannabis distributed nationwide.

Portfolio Pulse from Jelena Martinovic

February 06, 2024 | 3:51 pm

Ohio lawmakers are working on rules for legal adult-use cannabis sales, with optimism for progress in the spring. The state's House Speaker and Senate President are aiming for legislative action following the legalization vote two months ago. Meanwhile, experts at Crain's Cleveland Business Cannabis Summit discussed the potential and challenges of the new market. Companies like Green Thumb Industries, Curaleaf Holdings, and Cresco Labs are preparing for the opportunity.

Portfolio Pulse from Jelena Martinovic

January 29, 2024 | 3:04 pm

Cannabis stocks experienced significant volatility on January 26, 2024, with Corbus Pharmaceuticals leading the gainers with a 240.88% increase, while Blueberries Medical topped the losers with a 27.49% decline. Other notable movers included SOL Global Investments, C21 Investments, and OrganiGram Holdings with substantial gains, and 1933 Industries, Target Group, and Item 9 Labs with notable losses.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 9:30 pm

Ohio's medical cannabis sales reached a record $484.4 million in 2023, but the growth rate has stagnated to only 1.2% year-over-year. The market has seen declining growth rates since its inception, with revenue increases dropping from 297% in 2020 to just 1% in 2023. Despite selling 39% more plant material and 25% more manufactured products in 2023 than in 2022, the average flower retail price fell by 37%. Companies like Green Thumb Industries Inc. (GTBIF), Curaleaf Holdings Inc. (CURLF), and Cresco Labs Inc. (CRLBF) are preparing for Ohio's upcoming recreational cannabis market, which was legalized in November but has not yet commenced sales.

Portfolio Pulse from Jelena Martinovic

January 25, 2024 | 6:48 pm

Colorado lawmakers introduced a bipartisan measure to simplify cannabis regulations, including eliminating mandatory Aspergillus fungus testing. The bill also addresses labeling mandates, allows dispensaries to sell non-cannabis consumable goods, and extends licensure from one to two years. Publicly traded companies in Colorado like Green Thumb Industries, Schwazze, and Charlotte’s Web Holdings could be affected. Curaleaf Holdings exited Colorado last year.

Portfolio Pulse from Jelena Martinovic

January 25, 2024 | 3:11 pm

Pablo Zuanic's Q4 2023 cannabis sector report highlights state-specific market trends, with Connecticut, Ohio, Illinois, Maryland, and Rhode Island showing growth. Companies like MariMed, Verano, and Green Thumb Industries benefit from diversified state exposure. The report discusses MSO performance variations, regulatory developments, and potential political shifts that could impact the market. Key players in various states are analyzed, with the DEA's response to cannabis rescheduling being a significant upcoming event.

Portfolio Pulse from Nicolás Jose Rodriguez

January 23, 2024 | 8:38 pm

The Travel Agency: A Cannabis Store and Curaleaf Holdings Inc. (OTC:CURLF) are expanding their presence in New York's legal cannabis market. The Travel Agency is opening its second Brooklyn dispensary near the Barclays Center, while Curaleaf is launching its first adult-use store in Newburgh. New York's legal cannabis market faces challenges from unlicensed stores and generated $150 million in sales in its first year. Governor Hochul proposes legislative changes to improve the market's competitiveness.

Portfolio Pulse from Nicolás Jose Rodriguez

January 22, 2024 | 9:03 pm

Cannabis stocks experienced significant movements on January 19, 2024. EVIO led the gainers with a 9900.00% increase, while Rocky Mountain High topped the losers with a 21.62% decline. Notable gainers included Genetic Technologies, OrganiGram Holdings, and Cara Therapeutics, with increases of 42.16%, 10.72%, and 4.80% respectively. Among the losers, Corbus Pharmaceuticals and Greenlane Holdings saw declines of 4.91% and 3.32%.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 9:30 pm

The cannabis sector experienced bearish sentiment on January 18, 2024, with a mix of gainers and losers. Notable gainers included Genetic Technologies (GENE) and Urban-gro (UGRO), while significant losers were Aurora Cannabis (ACB), GrowGeneration (GRWG), OrganiGram Holdings (OGI), Tilray Brands (TLRY), Neptune Wellness Solutions (NEPT), Canopy Growth (CGC), Corbus Pharmaceuticals (CRBP), and Village Farms International (VFF).

Portfolio Pulse from Benzinga Insights

January 18, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.